Slow CCL2-dependent translocation of biopersistent particles from muscle to brain

BMC Medicine

Volumn 11, Issue 1, 2013, Pages

  Khan, Zakir ^a,b   Combadière, Christophe ^c,d,e   Authier, François Jérôme ^a,b,f   Itier, Valérie ^a,b,k   Lux, François ^g,h   Exley, Christopher ⁱ   Mahrouf Yorgov, Meriem ^a,b,k   Decrouy, Xavier ^a,b   Moretto, Philippe ^j   Tillement, Olivier ^g,h   Gherardi, Romain K ^a,b,f   Cadusseau, Josette ^a,b,k  

^a INSERM U955   (France)

^b FACULTÉ DE MÉDECINE   (France)

^c INSERM   (France)

^d SORBONNE UNIVERSITÉ   (France)

^e PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^f HENRI MONDOR HOSPITAL   (France)

^g University of Lyon   (France)

^h UNIVERSITÉ LYON 1   (France)

ⁱ KEELE UNIVERSITY   (United Kingdom)

^j CENTRE D ETUDES NUCLÉAIRES DE BORDEAUX GRADIGNAN   (France)

^k UNIVERSITÉ PARIS EST CRÉTEIL   (France)

more..

Author keywords

Alum; CCL 2; Macrophages; Macrophagic myofasciitis; Nanomaterial biodistribution; Nanomaterial neurodelivery; Single nucleotide polymorphisms (SNPs); Vaccine adjuvant; Vaccine adverse effect

Indexed keywords

ADJUVANT; ALUMINUM; ALUMINUM POTASSIUM SULFATE; CD11B ANTIGEN; CHEMOATTRACTANT; MONOCYTE CHEMOTACTIC PROTEIN 1; NANOMATERIAL;

ABLATION THERAPY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; BIOACCUMULATION; BLOOD BRAIN BARRIER; BRAIN; CELL LINEAGE; CONTROLLED STUDY; DIFFUSION; GAIN OF FUNCTION MUTATION; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNIZATION; LYMPH NODE; MICROGLIA; MONOCYTE; MOUSE; MUSCLE; NERVE CELL; NEUROTOXICITY; NONHUMAN; PHAGOCYTE; SINGLE NUCLEOTIDE POLYMORPHISM; SPLEEN; TISSUES;

ADJUVANTS, IMMUNOLOGIC; ALUM COMPOUNDS; ANIMALS; ASIA; BLOOD-BRAIN BARRIER; BRAIN; CELL MOVEMENT; CHEMOKINE CCL2; HUMANS; IMMUNIZATION; INJECTIONS, INTRAMUSCULAR; MALE; MICE; MICE, INBRED C57BL; MONOCYTES; MUSCLES; NANOPARTICLES; TISSUE DISTRIBUTION; VACCINES; VIRION;

EID: 84875890248     PISSN: None     EISSN: 17417015     Source Type: Journal    
DOI: 10.1186/1741-7015-11-99     Document Type: Article

References (50)

1. Committees on toxicity, mutagenicity and carcinogenicity of chemicals in food, consumer products and the environment (COT, COM, COC). Joint statement on nanomaterial toxicology 2005, Available at http://cot.food.goc.uk/pdfs/cotstatements2005nanomats.pdf.
2. Dobrovolskaia MA, Aggarwal P, Hall JB, McNeil SE. Preclinical studies to understand nanoparticle interaction with the immune system and its potential effects on nanoparticle biodistribution. Mol Pharm 2008, 5:487-495. 10.1021/mp800032f, 2613572, 18510338.
3. Exley C, Siesjö P, Eriksson H. The immunobiology of aluminium adjuvants: how do they really work?. Trends Immunol 2010, 31:103-109. 10.1016/j.it.2009.12.009, 20153253.
4. Gherardi RK, Coquet M, Cherin P, Belec L, Moretto P, Dreyfus PA, Pelissier JF, Chariot P, Authier FJ. Macrophagic myofasciitis lesions assess long-term persistence of vaccine-derived aluminium hydroxide in muscle. Brain 2001, 124:1821-1831. 10.1093/brain/124.9.1821, 11522584.
5. Authier FJ, Cherin P, Creange A, Bonnotte B, Ferrer X, Abdelmoumni A, Ranoux D, Pelletier J, Figarella-Branger D, Granel B, Maisonobe T, Coquet M, Degos JD, Gherardi RK. Central nervous system disease in patients with macrophagic myofasciitis. Brain 2001, 124:974-983. 10.1093/brain/124.5.974, 11335699.
6. Gherardi RK, Authier FJ. Aluminum inclusion macrophagic myofasciitis: a recently identified condition. Immunol Allergy Clin North Am 2003, 23:699-712. 10.1016/S0889-8561(03)00095-X, 14753387.
7. Shoenfeld Y, Agmon-Levin N. 'ASIA' - autoimmune/inflammatory syndrome induced by adjuvants. J Autoimmun 2010, 36:4-8.
8. Authier FJ, Sauvat S, Champey J, Drogou I, Coquet M, Gherardi RK. Chronic fatigue syndrome in patients with macrophagic myofasciitis. Arthritis Rheum 2003, 48:569-570. 10.1002/art.10740, 12571868.
9. Couette M, Boisse MF, Maison P, Brugieres P, Cesaro P, Chevalier X, Gherardi RK, Bachoud-Levi AC, Authier FJ. Long-term persistence of vaccine-derived aluminum hydroxide is associated with chronic cognitive dysfunction. J Inorg Biochem 2009, 103:1571-1578. 10.1016/j.jinorgbio.2009.08.005, 19748679.
10. Flarend RE, Hem SL, White JL, Elmore D, Suckow MA, Rudy AC, Dandashli EA. In vivo absorption of aluminium-containing vaccine adjuvants using 26Al. Vaccine 1997, 15:1314-1318. 10.1016/S0264-410X(97)00041-8, 9302736.
11. Morefield GL, Sokolovska A, Jiang D, HogenEsch H, Robinson JP, Hem SL. Role of aluminum-containing adjuvants in antigen internalization by dendritic cells in vitro. Vaccine 2005, 23:1588-1595. 10.1016/j.vaccine.2004.07.050, 15694511.
12. Hamilton JA, Byrne R, Whitty G. Particulate adjuvants can induce macrophage survival, DNA synthesis, and a synergistic, proliferative response to GM-CSF and CSF-1. J Leukoc Biol 2000, 67:226-232.
13. Verdier F, Burnett R, Michelet-Habchi C, Moretto P, Fievet-Groyne F, Sauzeat E. Aluminium assay and evaluation of the local reaction at several time points after intramuscular administration of aluminium containing vaccines in the Cynomolgus monkey. Vaccine 2005, 23:1359-1367. 10.1016/j.vaccine.2004.09.012, 15661384.
14. Authier FJ, Sauvat S, Christov C, Chariot P, Raisbeck G, Poron MF, Yiou F, Gherardi R. AlOH3-adjuvanted vaccine-induced macrophagic myofasciitis in rats is influenced by the genetic background. Neuromuscul Disord 2006, 16:347-352. 10.1016/j.nmd.2006.02.004, 16616846.
15. Brigitte M, Schilte C, Plonquet A, Baba-Amer Y, Henri A, Charlier C, Tajbakhsh S, Albert M, Gherardi RK, Chrétien F. Muscle resident macrophages control the immune cell reaction in a mouse model of notexin-induced myoinjury. Arthritis Rheum 2010, 62:268-279. 10.1002/art.27183, 20039420.
16. Carbone FR, Belz GT, Heath WR. Transfer of antigen between migrating and lymph node-resident DCs in peripheral T-cell tolerance and immunity. Trend Immunol 2004, 25:655-658.
17. Wang XY, Yao X, Wan YM, Wang B, Xu JQ, Wen YM. Responses to multiple injections with alum alone compared to injections with alum adsorbed to proteins in mice. Immunol Lett 2012, 149:88-92.
18. Cain DW, Sanders SE, Cunningham MM, Kelsoe G. Disparate adjuvant properties among three formulations of "alum". Vaccine 2013, 31:653-660. 10.1016/j.vaccine.2012.11.044, 23200935.
19. Moretto P. Nuclear microprobe: a microanalytical technique in biology. Cell Mol Biol 1996, 42:1-16.
20. Wen GY, Wisniewski HM. Histochemical localization of aluminum in the rabbit CNS. Acta Neuropathol 1985, 68:175-184. 10.1007/BF00690191, 2417440.
21. Redhead K, Quinlan GJ, Das RG, Gutteridge JM. Aluminium-adjuvanted vaccines transiently increase aluminium levels in murine brain tissue. Pharmacol Toxicol 1992, 70:278-280. 10.1111/j.1600-0773.1992.tb00471.x, 1608913.
22. Sahin G, Varol I, Temizer A, Benli K, Demirdamar R, Duru S. Determination of aluminum levels in the kidney, liver, and brain of mice treated with aluminium hydroxide. Biol Trace Elem Res 1994, 41:129-135. 10.1007/BF02917223, 7946900.
23. Kivelä R, Silvennoinen M, Lehti M, Kainulainen H, Vihko V. Effects of acute exercise, exercise training, and diabetes on the expression of lymphangiogenic growth factors and lymphatic vessels in skeletal muscle. Am J Physiol Heart Circ Physiol 2007, 293:H2573-H2590. 10.1152/ajpheart.00126.2007, 17766486.
24. Randolph GJ, Inaba K, Robbiani DF, Steinman RM, Muller WA. Differentiation of phagocytic monocytes into lymph node dendritic cells in vivo. Immunity 1999, 11:753-761. 10.1016/S1074-7613(00)80149-1, 10626897.
25. Allan RS, Waithman J, Bedoui S, Jones CM, Villadangos JA, Zhan Y, Lew AM, Shortman K, Heath WR, Carbone FR. Migratory dendritic cells transfer antigen to a lymph node-resident dendritic cell population for efficient CTL priming. Immunity 2006, 25:153-162. 10.1016/j.immuni.2006.04.017, 16860764.
26. Arnold L, Henry A, Poron F, Baba-Amer Y, van Rooijen N, Plonquet A, Gherardi RK, Chazaud B. Inflammatory monocytes recruited after skeletal muscle injury switch into antiinflammatory macrophages to support myogenesis. J Exp Med 2007, 204:1057-1069. 10.1084/jem.20070075, 2118577, 17485518.
27. Nico B, Frigeri A, Nicchia GP, Corsi P, Ribatti D, Quondamatteo F, Herken R, Girolamo F, Marzullo A, Svelto M, Roncali L. Severe alterations of endothelial and glial cells in the blood-brain barrier of dystrophic mdx mice. Glia 2003, 42:235-251. 10.1002/glia.10216, 12673830.
28. Fizet J, Rivière C, Bridot L, Charvet N, Louis C, Billotey C, Raccurt M, Morel G, Roux S, Perriat P, Tillement O. Multi-luminescent hybrid gadolinium oxide nanoparticles as potential cell labeling. J Nanosci Nanotechnol 2009, 9:5717-5725. 10.1166/jnn.2009.1237, 19908443.
29. Hornung V, Bauernfeind F, Halle A, Samstad EO, Kono H, Rock KL, Fitzgerald KA, Latz E. Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nat Immunol 2008, 9:847-856. 10.1038/ni.1631, 2834784, 18604214.
30. Weller RO, Djuanda E, Yow HY, Carare RO. Lymphatic drainage of the brain and the pathophysiology of neurological disease. Acta Neuropathol 2009, 117:1-14. 10.1007/s00401-008-0457-0, 19002474.
31. Kabashima K, Banks TA, Ansel KM, Lu TT, Ware CF, Cyster JG. Intrinsic lymphotoxin-beta receptor requirement for homeostasis of lymphoid tissue dendritic cells. Immunity 2005, 22:439-450. 10.1016/j.immuni.2005.02.007, 15845449.
32. Angeli V, Ginhoux F, Llodrà J, Quemeneur L, Frenette PS, Skobe M, Jessberger R, Merad M, Randolph GJ. B cell-driven lymphangiogenesis in inflamed lymph nodes enhances dendritic cell mobilization. Immunity 2006, 24:203-215. 10.1016/j.immuni.2006.01.003, 16473832.
33. Cavanagh LL, Bonasio R, Mazo IB, Halin C, Cheng G, van der Velden AW, Cariappa A, Chase C, Russell P, Starnbach MN, Koni PA, Pillai S, Weninger W, von Andrian UH. Activation of bone marrow-resident memory T cells by circulating antigen-bearing dendritic cells. Nat Immunol 2005, 6:1029-1037. 10.1038/ni1249, 1780273, 16155571.
34. Rimaniol AC, Gras G, Verdier F, Capel F, Grigoriev VB, Porcheray F, Sauzeat E, Fournier JG, Clayette P, Siegrist CA, Dormont D. Aluminum hydroxide adjuvant induces macrophage differentiation towards a specialized antigen-presenting cell type. Vaccine 2004, 22:3127-3135. 10.1016/j.vaccine.2004.01.061, 15297065.
35. Kool M, Soullié T, van Nimwegen M, Willart MA, Muskens F, Jung S, Hoogsteden HC, Hammad H, Lambrecht BN. Alum adjuvant boosts adaptive immunity by inducing uric acid and activating inflammatory dendritic cells. J Exp Med 2008, 205:869-882. 10.1084/jem.20071087, 2292225, 18362170.
36. Hall JG. Studies on the adjuvant action of beryllium, I. Effects on individual lymph nodes. Immunology 1998, 53:105-113.
37. Ajami B, Bennett JL, Krieger C, Tetzlaff W, Rossi FM. Local self-renewal can sustain CNS microglia maintenance and function throughout adult life. Nat Neurosci 2007, 10:1538-1543. 10.1038/nn2014, 18026097.
38. Mildner A, Schmidt H, Nitsche M, Merkler D, Hanisch UK, Mack M, Heikenwalder M, Brück W, Priller J, Prinz M. Microglia in the adult brain arise from Ly-6ChiCCR2+ monocytes only under defined conditions. Nat Neurosci 2007, 10:1544-1553. 10.1038/nn2015, 18026096.
39. Prinz M, Mildner A. Microglia in the CNS: immigrants from another world. Glia 2011, 59:177-187. 10.1002/glia.21104, 21125659.
40. Inoue K, Takano H, Yanagisawa R, Koike E, Shimada A. Size effects of latex nanomaterials on lung inflammation in mice. Toxicol Appl Pharmacol 2009, 234:68-76. 10.1016/j.taap.2008.09.012, 18938192.
41. Pauluhn J. Pulmonary toxicity and fate of agglomerated 10 and 40 nm aluminium oxyhydroxides following 4-week inhalation exposure of rats: toxic effects are determined by agglomerated, not primary particle size. Toxicol Sci 2009, 109:152-167. 10.1093/toxsci/kfp046, 19251949.
42. Persidsky Y, Stins M, Way D, Witte MH, Weinand M, Kim KS, Bock P, Gendelman HE, Fiala M. A model for monocyte migration through the blood-brain barrier during HIV-1 encephalitis. J Immunol 1997, 158:3499-3510.
43. Si Y, Tsou CL, Croft K, Charo IF. CCR2 mediates hematopoietic stem and progenitor cell trafficking to sites of inflammation in mice. J Clin Invest 2010, 120:1192-1203. 10.1172/JCI40310, 2846049, 20234092.
44. Palframan RT, Jung S, Cheng G, Weninger W, Luo Y, Dorf M, Littman DR, Rollins BJ, Zweerink H, Rot A, von Andrian UH. Inflammatory chemokine transport and presentation in HEV: a remote control mechanism for monocyte recruitment to lymph nodes in inflamed tissues. J Exp Med 2001, 5:1361-1373.
45. Chackerian AA, Alt JM, Perera TV, Dascher CC, Behar SM. Dissemination of Mycobacterium tuberculosis is influenced by host factors and precedes the initiation of T-cell immunity. Infect Immun 2002, 70:4501-4509. 10.1128/IAI.70.8.4501-4509.2002, 128141, 12117962.
46. Drevets DA, Dillon MJ, Schawang JS, Van Rooijen N, Ehrchen J, Sunderkötter C, Leenen PJ. The Ly-6Chigh monocyte subpopulation transports Listeria monocytogenes into the brain during systemic infection of mice. J Immunol 2004, 172:4418-4424.
47. Eugenin EA, Osiecki K, Lopez L, Goldstein H, Calderon TM, Berman JW. CCL2/monocyte chemoattractant protein-1 mediates enhanced transmigration of human immunodeficiency virus (HIV)-infected leukocytes across the blood-brain barrier: a potential mechanism of HIV-CNS invasion and NeuroAIDS. J Neurosci 2006, 26:1098-1106. 10.1523/JNEUROSCI.3863-05.2006, 16436595.
48. Gonzalez E, Rovin BH, Sen L, Cooke G, Dhanda R, Mummidi S, Kulkarni H, Bamshad MJ, Telles V, Anderson SA, Walter EA, Stephan KT, Deucher M, Mangano A, Bologna R, Ahuja SS, Dolan MJ, Ahuja SK. HIV-1 infection and AIDS dementia are influenced by a mutant MCP-1 allele linked to increased monocyte infiltration of tissues and MCP-1 levels. Proc Natl Acad Sci U S A 2002, 99:13795-13800. 10.1073/pnas.202357499, 129777, 12374865.
49. Shaw CA, Petrik MSJ. Aluminum hydroxide injections lead to motor deficits and motor neuron degeneration. J Inorg Biochem 2009, 103:1555-1562. 10.1016/j.jinorgbio.2009.05.019, 2819810, 19740540.
50. Galimberti D, Fenoglio C, Lovati C, Venturelli E, Guidi I, Corra B, Scalabrini D, Clerici F, Mariani C, Bresolin N, Scarpini E. Serum MCP-1 levels are increased in mild cognitive impairment and mild Alzheimer's disease. Neurobiol Aging 2006, 27:1763-1768. 10.1016/j.neurobiolaging.2005.10.007, 16307829.